statistiche ricercatore

Continente	#
NA - Nord America	363
EU - Europa	268
AS - Asia	266
SA - Sud America	36
AF - Africa	23
Continente sconosciuto - Info sul continente non disponibili	1
OC - Oceania	1
Totale	958

Nazione	#
US - Stati Uniti d'America	350
SG - Singapore	81
IT - Italia	77
CN - Cina	76
IE - Irlanda	42
RU - Federazione Russa	37
HK - Hong Kong	35
DE - Germania	31
VN - Vietnam	31
BR - Brasile	27
FI - Finlandia	24
FR - Francia	14
ZA - Sudafrica	13
GB - Regno Unito	11
IN - India	11
SE - Svezia	7
CA - Canada	6
MX - Messico	6
BE - Belgio	5
JP - Giappone	5
IQ - Iraq	4
NL - Olanda	4
PK - Pakistan	4
PL - Polonia	4
AR - Argentina	3
CO - Colombia	3
CZ - Repubblica Ceca	3
LT - Lituania	3
MA - Marocco	3
BD - Bangladesh	2
LK - Sri Lanka	2
MU - Mauritius	2
VE - Venezuela	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
AT - Austria	1
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BH - Bahrain	1
CR - Costa Rica	1
EE - Estonia	1
EG - Egitto	1
ES - Italia	1
ET - Etiopia	1
GE - Georgia	1
GR - Grecia	1
HU - Ungheria	1
ID - Indonesia	1
IL - Israele	1
IR - Iran	1
JO - Giordania	1
KE - Kenya	1
KG - Kirghizistan	1
KW - Kuwait	1
NP - Nepal	1
PH - Filippine	1
PS - Palestinian Territory	1
PY - Paraguay	1
SN - Senegal	1
TH - Thailandia	1
TN - Tunisia	1
TR - Turchia	1
Totale	958

Nome	#
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy	146
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme	135
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy	131
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count	125
Sars-cov-2 virologic and immunologic correlates in patients with olfactory and taste disorders	88
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: Final results from an expanded-access trial	87
Clinical and analytical performance of an automated serological test that identifies s1/s2-neutralizing igg in covid-19 patients semiquantitatively	74
Corrigendum to "Seroprevalence of SARS-CoV-2 in 1922 blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area" [Clin Microbiol Infect 27 (6) (2021 Jun) 914.e1-914.e4]	63
Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area	62
A Multicenter Study in Northern Italy to Evaluate the Impact of a Sepsis Bundle in Obstetric Settings: The SOS Study	43
Risk of Congenital Toxoplasmosis in Newborns from Mothers with Documented Infection: Experience from Two Referral Centres	16
Totale	970

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	4	0	0	0	0	0	0	0	0	0	0	3	1
2021/2022	51	1	1	5	1	1	3	3	4	3	3	2	24
2022/2023	142	9	8	3	9	5	14	0	4	51	0	36	3
2023/2024	85	8	12	3	5	6	13	5	3	0	6	17	7
2024/2025	212	6	18	5	9	6	18	9	4	54	16	22	45
2025/2026	441	30	28	50	59	54	20	82	40	51	27	0	0
Totale													970